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Abstract 
Review on t(1;12)(q21;p13) ETV6/ARNT, with 
data on clinics, and the genes implicated. 
Clinics and pathology 
Disease 
Myeloid and lymphoid malignancies 
Note 
Excluded from this review is a case of multiple 
myeloma (Lewis and MacKenzie, 1984). 
Phenotype/cell stem origin 
Two cases of acute lympoblastic leukemia (ALL) 
have been described with a t(1;12)(q21;p13): an 
ALL not otherwise specified (NOS) in a female 
patient with no indication concerning the genes 
involved (Heerema et al., 2004), and a T-cell ALL 
(CD5+, CD7+, CD4-, CD8-) in a 2-year old boy, 
and with assessement of an ETV6/ARNT transcript 
(Otsubo et al., 2010). Three myeloid cases are 
available: a chronic myelogenous leukemia in blast 
crisis (BC-CML) in a female patient without 
molecular data (Palandri et al., 2009), a M2 acute 
myeloblastic leukemia (M2-AML) in a 5-year old 
boy with an ETV6/ARNT transcript (Berger et al., 
1997; Salomon-Nguyen et al., 2000), and a case of 
refractory anemia with excess blasts in 
transformation (RAEB-t) with total absence of 
erythroid precursors in bone marrow in a 64-year 
old male patient, where ETV6 may not be involved 
(Sánchez et al., 2000). 
Epidemiology 
In this small series, 2 of 3 cases, however, are 
found in pediatric patients. 
Prognosis 
Very scarce data: the BC-CML patient died 47 
months after diagnosis. 
Cytogenetics 
Cytogenetics morphological 
A del(7q) was found in an ALL case, a 
t(9;22)(q34;q11) in the BC-CML case, indeed, and 
the t(1;12) was the sole anomaly in the RAEB-t 
case. 
Genes involved and 
proteins 
Note 
An ETV6/ARNT hybrid transcript has therefore 
been described in two cases: a case of T-ALL, and a 
case of M2-AML.  
The breakpoint appears to be identical in the two 
cases: ETV6 exon 4 fused to the ARNT exon 2 
(Otsubo et al., 2010), breakpoint after the 154 first 
amino acids in ETV6 and after the 8 first amino 
acids in ARNT (Salomon-Nguyen et al., 2000). 
ARNT 
Location 
1q21 
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Protein 
789 amino acids. ARNT is composed of a bHLH, 
basic helix-loop-helix domain, 2PAS, 
Per/ARNT/Sim homology domains, and a 
glutamine-rich transactivation domain. 
Transcription factor. Forms homodimers or 
hetrodimers with AHR (7p21); mediates the cellular 
response to xenobiotic compounds such as 
environmental pollutants. Interacts with estrogen 
receptors (ER). ARNT is recruited to estrogen-
responsive promoters, leading to increased ER 
transcription (reviews in Hankinson, 2004; 
Swedenborg and Pongratz, 2010). 
ETV6 
Location 
12p13 
Protein 
452 amino acids. ETV6 is composed of a HLH 
domain responsible for hetero- and 
homodimerization in N-term, and an ETS domain 
responsible for sequence specific DNA-binding in 
C-term (binds to the DNA sequence 5'-
CCGGAAGT-3').  
Transcriptional regulator; tumor suppressor. 
Involved in bone marrow hematopoiesis. 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
ETV6 exon 4 was fused in frame to the ARNT exon 
2 (Otsubo et al., 2010). 
Fusion protein 
Description 
Two fusion proteins are found as a result of this 
translocation. The ETV6/ARNT protein contains 
the 154 first amino acids, including the 
aminoterminal oligomerization domain of ETV6 
and most of the ARNT protein, and is highly 
expressed in the leukemic cells of the patient 
(Salomon-Nguyen et al., 2000).  
The ARNT/ETV6 protein contains the first 8 amino 
acids of ARNT fused to the 298 carboxyl-terminal 
amino acids of ETV6 including its ETS DNA-
binding domain.  
This protein is hardly expressed and is likely to be 
not involved in the malignant process (Salomon-
Nguyen et al., 2000). 
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